CEMACH

Chapter 15: Pathology

References

  1. www.rcpath.org/publications

  2. Lewis G, Drife J (eds) “Why Mothers Die 1997-9 “ The Fifth Report of the United Kingdom Confidential Enquiry into Maternal Deaths. London RCOG Press 2001.

  3. Millward-Sadler GH, 2003, Pathology of maternal deaths. In: Kirkham N, Shepherd N, editors. Progress in Pathology, Vol 6, 163-85. London, Greenwich Medical Media Ltd.

  4.   Clark SL, Pavlova Z, Greenspoon J, et al. 1986, Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol; 154, 104-6.

  5. Benson MD, Kobayashi H, Silver RK, et al. 2001, Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 97(4), 510-4.

  6. Kobayashi H, Hidekazu O, Hayakawa H, et al. 1997, Histological diagnosis of amniotic fluid embolus by monoclonal antibody TKH-2 that recognises NeuAc a 2-6GalNAc epitope. Human Pathology, 28, 428-33.

  7. Oi H. Kobayashi H., Hirashima Y., et al 1998, Serological and immunohistochemical diagnosis of amniotic fluid embolism. Semin Thromb Hemost., 24(5), 479-84.

  8. Health Protection Agency. 2004, First year of enhanced surveillance of Group A streptococcal infections. Commun. Dis. Rep. Wkly. 14 (16)

  9. Smahi A., Courtois G., Rabia SH., et al, 2002, The NF-KappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11, 2371-5.

  10. Kishkurno S., Ishida A., Takahashi Y., et al, 1997 A case of neonatal choriocarcinoma. American J. of Perinatal 1997, 14, 79-82.

  11. Tsukamoto N, Matsumura M, Matsukuma K, et al. 1986 Choriocarcinoma in mother and fetus. Gynaecological Oncology, 24, 113-9.

  12. Jarmulowicz M, and Philips WG, 2001, Vascular Ehlers-Danlos syndrome undiagnosed during life. J. Royal Society of Medicine, 94, 28-30.

  13. Jouven X, Charles M-A, Desnos M & Duciemetiere. 2001, Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation, 104, 756-61.

  14. Ferns G. Personal communication.

  15. Grundy SM, Brewer, HB Jr, Cleeman JI, et al., 2004, Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation; 109, 433-438.

  16. Tan HL, Hofman N, van Langen IM, et al. 2005, Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation, 112, 207-13.

  17. Halliday DJ, Hutchinson S, Lonie L, et al, 2002, Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice. Journal Medical Genetics, 39, 589-93.

  18. Jonasson B & Saldeen T. 2002, Citalopram in fatal poisoning cases. Forensic Science International, 2002, 126, 1-6.

  19. Geocadin RG, Razumovsky AY, Wityk RJ, et al. 2002, Intracerebral haemorrhage and postpartum vasculopathy. J. Neurol Sci. 205, 29-34.

  20. Witlin AG, Mattar F, Sibai BM. 2000, Postpartum stroke: a twenty year experience. Am J Obst Gyn, 183, 83-88.

  21. Edmondson H A, Peters R L, Reynolds T B, Kuzma O T, 1963, Sclerosing hyaline necrosis of the liver. A recognizable clinical syndrome. Annals of Internal Medicine, 59, 646-73 .